Researchers found that plasma biomarker sST2 independently predicts adverse clinical outcomes in diverse populations of patients with acute respiratory failure.
The post Plasma Biomarker Predicts Adverse ARF Clinical Outcomes first appeared on Physician’s Weekly.
